Dynavax stock drops following Goldman Sachs downgrade
Goldman Sachs analyst Paul Choi downgraded the stock from "Neutral" to "Sell," setting a price target of $12, which is ...
Goldman Sachs cuts Dynavax stock rating to sell, target to $12
Goldman Sachs downgraded Dynavax Technologies Corporation (NASDAQ:DVAX) stock from Neutral to Sell, adjusting the price target downward to $12.00 from the previous $15.00. According to InvestingPro ...
Patty Murray: RFK Jr. meeting was most troubling she’s had in 32 years
In public confirmation hearings last month, Robert F. Kennedy Jr., President Donald Trump's nominee to lead the nation's ...
NanoViricides Drug Can Fight Bird Flu Pandemic; H5N1 Virus Cannot Escape
NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu ...